Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 13 | ||
Ligand | BDBM50473627 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_124318 (CHEMBL732626) | ||
IC50 | 6.0±n/a nM | ||
Citation | McKenna, JM; Halley, F; Souness, JE; McLay, IM; Pickett, SD; Collis, AJ; Page, K; Ahmed, I An algorithm-directed two-component library synthesized via solid-phase methodology yielding potent and orally bioavailable p38 MAP kinase inhibitors. J Med Chem45:2173-84 (2002) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 13 | |||
Name: | Mitogen-activated protein kinase 13 | ||
Synonyms: | MAP kinase 13 | MAP kinase p38 delta | MAPK 13 | MK13_MOUSE | Mapk13 | Mitogen-activated protein kinase 13 | Mitogen-activated protein kinase p38 delta | Serk4 | Stress-activated protein kinase 4 | ||
Type: | PROTEIN | ||
Mol. Mass.: | 42081.17 | ||
Organism: | Mus musculus | ||
Description: | ChEMBL_105000 | ||
Residue: | 366 | ||
Sequence: |
| ||
BDBM50473627 | |||
n/a | |||
Name | BDBM50473627 | ||
Synonyms: | CHEMBL308203 | RPR-239939 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H33FN6O4 | ||
Mol. Mass. | 512.5764 | ||
SMILES | CCCNC(=O)[C@@]1(C)CO[C@@H](OC1)c1nc(c([nH]1)-c1ccnc(NCCCOC)n1)-c1ccc(F)cc1 |wU:10.13,6.6,wD:6.5,(26.03,-17.02,;25.26,-15.68,;23.72,-15.68,;22.96,-14.34,;21.42,-14.34,;20.64,-15.67,;20.66,-13.01,;21.42,-11.67,;19.89,-11.68,;18.37,-11.67,;17.6,-13,;18.37,-14.33,;19.89,-14.33,;16.06,-13,;15.14,-14.24,;13.68,-13.75,;13.68,-12.21,;15.15,-11.75,;12.35,-11.44,;12.35,-9.89,;11.02,-9.12,;9.69,-9.89,;9.69,-11.44,;8.35,-12.21,;7.02,-11.44,;5.68,-12.21,;4.35,-11.44,;3.02,-12.2,;1.69,-11.43,;11.02,-12.21,;12.44,-14.65,;12.59,-16.18,;11.35,-17.08,;9.94,-16.45,;8.6,-17.21,;9.79,-14.91,;11.04,-14.01,)| | ||
Structure |